Please login to the form below

Not currently logged in
Email:
Password:

Bill would expand pharmacists' role

US Senator Kay Hagan has introduced a bill intended to expand the role of pharmacists in helping patients manage their medication

US Senator Kay Hagan, the Democrat from North Carolina, has introduced a bill intended to cut costs and increase patient compliance by expanding the role of pharmacists in helping patients manage their medication.

The proposed legislation, known as the Medication Therapy Management Expanded Benefits Act of 2010, builds on provisions in the healthcare reform law to enhance pharmacist-provided medication therapy management (MTM) services for Medicaid and Medicare beneficiaries by opening MTM services to patients suffering from any chronic condition or disease.

The bill, which is co-sponsored by the high-profile Minnesota Democrat Al Franken, has been endorsed by the National Association of Chain Drug Stores (NACDS) and National Community Pharmacists Association (NCPA).

"By encouraging MTM services in neighbourhood pharmacies, the bill would improve public health and reduce healthcare costs by helping patients to take their medications in the right ways and avoid complications with their drug therapies," said NACDS president and CEO Steven C Anderson. "Patients suffering from chronic disease, be it diabetes, hypertension, asthma or other conditions, will benefit from these pharmacy services, which also strengthen the pharmacist-patient relationship."

The legislation is the Senate's companion to a House bill, the Medication Therapy Management Benefits Act of 2009, which was introduced by Mike Ross, Democratic member of the United States House of Representatives, in Arkansas last year.

30th June 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics